Recognition mechanism of heterologous erythrocytes by the alternative pathway of complement.
Recognition mechanism of heterologous erythrocytes by the alternative pathway of complement.
批准号:
59580109
负责人:
TOMITA Motowo
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1984
资助国家:
日本
项目状态:
已结题
起止时间:
1984 至 1986
中文摘要
替代补体途径的激活不依赖于形成C3转换酶的抗原-抗体复合体。不同物种的交替途径不同,其识别功能的特异性不同。因此,人的替代途径是由兔红细胞激活的,而兔的替代途径是由人的红细胞激活的,显然该替代途径不被同源红细胞激活。因此,替代途径的组成部分区分同种和异种红细胞。在这个项目中,我试图确定在区分过程中起作用的组件。从人血和兔血中提纯了构成替代途径的6种成分(C3、B、D、P、H和I因子)。用相应的兔组分取代重组混合物,并用兔和人红细胞测定了取代的重组混合物的溶血活性。结果表明,C3是异种红细胞识别过程中的主要参与者,由于红细胞膜上的某些成分可能也参与了替代途径所表现出的识别过程,因此我试图对该成分进行鉴定。红细胞膜蛋白中最可能的候选蛋白似乎是DAF(C3,C5-转换酶的衰变加速因子)。用为本项目开发的方法从相应的红细胞膜中分离出人和兔的DAF。纯化的DAF对同源C3的亲和力高于对异源C3的亲和力,表明DAF参与了识别过程。
英文摘要
Activation of the alternative complement pathway is independent of antigen-antibody complex for formation of C3 convertase. The alternative pathway of various species differs in the specificity of their recognition function. Thus, human alternative pathway is activated by rabbit erythrocytes while rabbit alternative pathway is activated by human erythrocytes; it is evident that the alternative pathway is not activated by homologous erythrocytes. Therefore, components of the alternative pathway distinguish between homologous and heterologous erythrocytes. In this project, I tried to determine the components that play a role on the distinguishing process. All of the six components constituting the alternative pathway (C3, B, D, P, H and I factors)were purified from both of human and rabbit bloods. The reconstitution mixture were substituted with the corresponding rabbit components and the hemolytic activities of the substituted reconstitution mixtures were measured with rabbit and human erythrocytes. The results indicated that C3 was the major participant in the recognition process of heterologous erythrocytes.Since some components on erythrocyte membranes should be also responsible for the recognition process exhibited by the alternative pathway, I tried to identify the component. The most likely candidate among erythrocyte membrane proteins seemed to be DAF ( decay-accelerating factor of C3, C5-convertases ). Human and rabbit DAF's were isolated from the corresponding erythrocyte membranes by the methods developed for this project. DAF thus purified showed higher affinity to homologous C3 than to heterologous C3; indicating that DAF is a participant in the recognition process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Iijima,M.: J.Biochem.96. 1534-1546 (1984)
饭岛,M.:J.Biochem.96。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakano, Y.: "Isolation and characterization of rabbit H of the alternative complement pathway." J. Biochemistry. 95. 1469-1475 (1984)
Nakano, Y.:“补体旁路途径兔 H 的分离和表征。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
An Adipocyte-specific Plasma Protein, Adiponectin/GBP28, functions as a mediator of biological defense mechanism.
-
批准号:16590061
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:TOMITA Motowo
-
依托单位:
Characterization of physiological function of the plasma proteins, PFBP and IHRP with knockout mice.
-
批准号:11470489
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:1999
-
负责人:TOMITA Motowo
-
依托单位:
Biological functions of novel human plasma proteins, IHRP and PHBP.
-
批准号:08457615
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.06万
-
财政年份:1996
-
负责人:TOMITA Motowo
-
依托单位:
Search of a gene family containing MACIF, a regulatory membrane protein of complement system
-
批准号:02454487
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1990
-
负责人:TOMITA Motowo
-
依托单位:
Devlopment of MACIF as a new medicine for regulation of membrane attack complex of complement
-
批准号:02557103
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:1990
-
负责人:TOMITA Motowo
-
依托单位:
Structural analysis of regulatory factors of complement on erythrocyte membranes
-
批准号:62580132
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1987
-
负责人:TOMITA Motowo
-
依托单位:
海外基金